HomeCompareAURWF vs MRK

AURWF vs MRK: Dividend Comparison 2026

AURWF yields 71428.57% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AURWF wins by $1.6804617092236922e+25M in total portfolio value
10 years
AURWF
AURWF
● Live price
71428.57%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.6804617092236922e+25M
Annual income
$16,758,464,082,723,930,000,000,000,000,000.00
Full AURWF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — AURWF vs MRK

📍 AURWF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAURWFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AURWF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AURWF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AURWF
Annual income on $10K today (after 15% tax)
$6,071,428.57/yr
After 10yr DRIP, annual income (after tax)
$14,244,694,470,315,339,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, AURWF beats the other by $14,244,694,470,315,339,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AURWF + MRK for your $10,000?

AURWF: 50%MRK: 50%
100% MRK50/50100% AURWF
Portfolio after 10yr
$8.402308546118461e+24M
Annual income
$8,379,232,041,361,964,000,000,000,000,000.00/yr
Blended yield
99.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AURWF
No analyst data
Altman Z
-14.7
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AURWF buys
0
MRK buys
0
No recent congressional trades found for AURWF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAURWFMRK
Forward yield71428.57%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.6804617092236922e+25M$56.8K
Annual income after 10y$16,758,464,082,723,930,000,000,000,000,000.00$9,798.13
Total dividends collected$1.6801590475897682e+25M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AURWF vs MRK ($10,000, DRIP)

YearAURWF PortfolioAURWF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$7,153,557$7,142,857.14$11,206$366.19+$7.14MAURWF
2$4,783,059,608$4,775,405,302.31$12,650$502.35+$4783.05MAURWF
3$2,989,196,089,253$2,984,078,215,471.53$14,407$694.19+$2989196.07MAURWF
4$1,746,108,740,720,723$1,742,910,300,905,223.00$16,585$967.82+$1746108740.70MAURWF
5$953,366,906,359,837,700$951,498,570,007,266,600.00$19,342$1,363.89+$953366906359.82MAURWF
6$486,546,837,026,708,500,000$485,526,734,436,903,500,000.00$22,913$1,947.19+$486546837026708.50MAURWF
7$232,096,820,383,666,640,000,000$231,576,215,268,048,070,000,000.00$27,662$2,823.89+$232096820383666624.00MAURWF
8$103,489,940,016,498,150,000,000,000$103,241,596,418,687,620,000,000,000.00$34,159$4,173.35+$103489940016498147328.00MAURWF
9$43,133,653,750,454,530,000,000,000,000$43,022,919,514,636,880,000,000,000,000.00$43,337$6,308.80+$4.313365375045453e+22MAURWF
10$16,804,617,092,236,920,000,000,000,000,000$16,758,464,082,723,930,000,000,000,000,000.00$56,776$9,798.13+$1.6804617092236922e+25MAURWF

AURWF vs MRK: Complete Analysis 2026

AURWFStock

Aurwest Resources Corporation, a junior resource company, engages in the acquisition, exploration, and evaluation of mineral properties in North America. The company primarily explores for gold and copper deposits. It holds 100% interests in the Stellar Copper-Gold Project covering an area of 24,533 ha located in British Columbia; and Stars copper porphyry project, consisting of four mineral tenures that covers an area of 3,761ha. The company also has option agreements to acquire 100% interest in the Paradise Lake, Miguels Lake, and the Stony Caldera gold properties covering an area of 47,800 hectares in Central Newfoundland. The company was formerly known as Shamrock Enterprises Inc. and changed its name to Aurwest Resources Corporation in January 2020. Aurwest Resources Corporation was incorporated in 2008 and is headquartered in Calgary, Canada.

Full AURWF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AURWF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AURWF vs SCHDAURWF vs JEPIAURWF vs OAURWF vs KOAURWF vs MAINAURWF vs JNJAURWF vs ABBVAURWF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.